Skip to content

Nikolina Markovic

NPI 1477165959ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Rapid City, SD

Internal Medicine, Endocrinology, Diabetes & Metabolism in Rapid City, South Dakota, licensed in SD, with an NPI issued in August 2020. Part D covered 120 prescriptions written in 2024, 62% of them generic. Novo Nordisk Inc was the largest of 2 companies reporting payments in 2025, $99.98 in all, mostly food and beverage.

Overview

NPI1477165959
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedAug 17, 2020
Last updated in NPPESJul 10, 2026
Certified by providerJul 10, 2026

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Endocrinology (SD)

Part D prescriptions in 2024

Prescriptions (claims)120 · 247 30-day fills
Patients37
Total drug cost$19,006
Generic share62% of claims

Medicare sources and data years

Education and affiliations

Graduation year2014
Medicare specialtyEndocrinology

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$99.98 · 2 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Novo Nordisk Inc$49.991
Amgen Inc.$49.991

What the 2025 payments were for

  • Food and Beverage$99.98 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Rapid City

All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in South Dakota →